Activity ID
14076Expires
December 10, 2025Format Type
LiveCME Credit
12Fee
$0CME Provider: Oregon Health & Science University School of Medicine
Description of CME Course
The purpose of this ECHO program is to support clinicians and their teams practicing in primary care clinics and other settings to identify and treat substance use disorders. There remains a signifcant gap between need and availability in regards to physician-administered bupernorphine and other MAT in Oregon.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Family Medicine
Preventive Medicine
Psychiatry and Neurology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
1. Learn to screen for and diagnose substance use disorders
2. Understand medications used to treat opioid use disorder, alcohol use disorder, and tobacco use disorder
3. Develop an approach to evaluating, treating, and differentially diagnosing substance-induced mental disorders and mental illnesses that tend to co-occur with substance use disorders.”
4. Understand harm reduction and its role in the treatment of substance use disorders
5. Understand evidence-based psychosocial interventions for substance use disorders
Competencies
Interpersonal & Communication Skills, Medical Knowledge, Patient Care & Procedural Skills, Systems-based Practice
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Academic Medicine, Outpatient, Rural, Urban, VA/Military
